SEC Filing Summary: Hexindai Inc. (Form 6-K)
Business Context and Reporting Period
This Form 6-K is filed by Hexindai Inc., a foreign private issuer, for the month of July 2019. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing was signed by Zhang Qisen (Johnson), Chief Financial Officer, on July 1, 2019. The filing includes a press release as Exhibit 99.1.
Financial Metrics
The provided filing text does not contain specific financial data. There are no reported values for revenue, profit, cash flow, margins, debt, or liquidity within this document.
Material Changes
The filing text does not provide information regarding material changes versus prior comparable periods.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. The content is limited to the cover page, signature block, and exhibit index.
Key Facts for Investor Verification
- Verify the content of the referenced Press Release (Exhibit 99.1) for actual financial or operational updates.
- Confirm the discrepancy between the request metadata ("Akso Health Group") and the registrant name in the filing ("Hexindai Inc.").
- Note that the signature date (July 1, 2019) precedes the end of the reporting period (July 31, 2019).